Despite its high accuracy, CTA can come with tradeoffs including requiring radiologists to review a high number of images looking for findings that can be subtle, increasing case complexity and workloads.
Umar Mahmood, MD, PhD, currently is chief of nuclear medicine and molecular imaging at Massachusetts General Hospital and a Harvard professor of radiology, will take on the title beginning Feb. 1.
Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%.
Rad Partners "firmly" denied the allegations, which mirror a similar complaint from Aetna, contending it plans to "vigorously defend against these claims" in court.
After losing a court battle with the Fortune 500 company last year, Jeffrey C. Allard, MD, and attorneys are homing in on an attorney's faulty credentials, claiming she "poisoned" the proceedings.
Vital Imaging Diagnostic Centers recently alerted patients about the apparent cyberattack with an unauthorized party likely gaining access to private health information.
The institution will utilize the Sectra One Cloud, seeking to improve workflows across its radiology, breast imaging, cardiology and orthopedic departments.
The Plantation, Florida, company first announced the initiative at RSNA 2024, offering clients new “relocatable and expandable” centers to be deployed across the U.S.
Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%.
